JD Health, the healthcare subsidiary of JD.com, a Chinese e-commerce giant, launched a “family doctor” service based on an “internet +healthcare” model earlier this week.
Up to eight family members may share a “family doctor” service package which includes unlimited 24/7 online medical consultation support with immediate response from a general practitioner, medical consultation with experts within 48 hours, making face-to-face appointments with famous doctors from 3A hospitals (Chinese hospitals are classified into 3 tiers with tier three being the highest and each tier is further classified into A, B or C sub-tiers. 3A represents the top-tier hospital), getting constant and personalized health management advice and more.
In a large country like China, getting access to top-tier hospitals can be difficult and JD Health’s “family doctor” service present an alternative for them to quickly connect with medical specialists and leading doctors online and offline.
According to JD Health, the company has recruited about 300 full-time doctors working as the core team for the “family doctor” services. 92% of doctors have more than 10 years of clinical experience.
In addition to seeing doctors online or offline, users can buy medicine on JD’s platform and enjoy its fast delivery service. There are over 220,000 healthcare products on JD Health ranging from OTC drugs, medicines for chronic diseases, medical equipment, and nutrition products.
THE LARGER TREND
While online medical consulting has been on the rise in China, the COVID-19 pandemic has accelerated its use and adoption. JD Health launched its free online consultation platform to deal with COVID-19 in late January this year and quickly expanded the scope of its free consultation services to cover all medical departments and diseases.
JD Health said that from late January to mid-April, its online consultation platform has responded to a total of more than 9 million inquiries, with an average daily consultation volume of more than 120,000.
DealstreetAsia recently reported that JD Health has entered a deal with Hillhouse to raise $830M in Series B funding. JD Health received $1B in Series A funding in 2019, led by JD.com with investors such as CICC Capital and Baring Private Equity Asia.
ON THE RECORD
“The core value of the ‘family doctor’ product exists in that it can offer different medical service formats based on patients’ need and match medical resources more accurately. Gathering more quality medical resources around users is what is really needed now. This new experience and business model will set a new benchmark in this industry,” said Lijun Xin, CEO of JD Health.